NO984164D0 - Bioconjugates of manganese or iron complexes consisting of nitrogen-containing macrocyclic ligands effective as catalysts for the dismutation of superoxide - Google Patents

Bioconjugates of manganese or iron complexes consisting of nitrogen-containing macrocyclic ligands effective as catalysts for the dismutation of superoxide

Info

Publication number
NO984164D0
NO984164D0 NO984164A NO984164A NO984164D0 NO 984164 D0 NO984164 D0 NO 984164D0 NO 984164 A NO984164 A NO 984164A NO 984164 A NO984164 A NO 984164A NO 984164 D0 NO984164 D0 NO 984164D0
Authority
NO
Norway
Prior art keywords
dismutation
bioconjugates
superoxide
catalysts
manganese
Prior art date
Application number
NO984164A
Other languages
Norwegian (no)
Other versions
NO984164L (en
Inventor
William L Neumann
Dennis P Riley
Randy H Weiss
Susan L Henke
Patrick J Lennon
Karl W Aston
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/012767 external-priority patent/WO1997006824A2/en
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of NO984164D0 publication Critical patent/NO984164D0/en
Publication of NO984164L publication Critical patent/NO984164L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
NO984164A 1996-03-13 1998-09-10 Bioconjugates of manganese or iron complexes consisting of nitrogen-containing macrocyclic ligands effective as catalysts for the dismutation of superoxide NO984164L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1334896P 1996-03-13 1996-03-13
PCT/US1996/012767 WO1997006824A2 (en) 1995-08-17 1996-08-14 Bioconjugates of manganese complexes and their application as catalysts
PCT/US1997/002566 WO1997033877A1 (en) 1996-03-13 1997-03-04 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide

Publications (2)

Publication Number Publication Date
NO984164D0 true NO984164D0 (en) 1998-09-10
NO984164L NO984164L (en) 1998-11-06

Family

ID=21759507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984164A NO984164L (en) 1996-03-13 1998-09-10 Bioconjugates of manganese or iron complexes consisting of nitrogen-containing macrocyclic ligands effective as catalysts for the dismutation of superoxide

Country Status (11)

Country Link
EP (1) EP0891338A1 (en)
JP (1) JP2000508625A (en)
KR (1) KR19990087784A (en)
CN (1) CN1225631A (en)
AU (1) AU1962497A (en)
BR (1) BR9708179A (en)
CA (1) CA2249011A1 (en)
CZ (1) CZ271198A3 (en)
IL (1) IL125889A0 (en)
NO (1) NO984164L (en)
WO (1) WO1997033877A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
ES2254142T3 (en) 1999-01-25 2006-06-16 National Jewish Medical And Research Center REPLACED PORPHIRINS AND THEIR THERAPEUTIC USE.
WO2000054784A1 (en) * 1999-03-15 2000-09-21 Abdurafik Bakhramovich Akbarov Complex comprising the coordination compound manganese, its medical effects and the mode of its production
AU5048400A (en) * 1999-05-27 2000-12-18 Monsanto Company Biomaterials modified with superoxide dismutase mimics
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
EP1439842A4 (en) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
KR20140001257A (en) 2008-05-13 2014-01-06 유니버시티 오브 캔사스 Metal abstraction peptide(map) tag and associated methods
RU2506083C2 (en) 2008-05-23 2014-02-10 Нэшнл Джуиш Хелт Method of treating disorders associated with alkylating agent exposure
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE164164T1 (en) * 1991-07-19 1998-04-15 Monsanto Co MANGANEOUS COMPLEXES WITH NITROGEN-CONTAINING MACROCYCLIC LIGANDS, ACTIVE AS SUPEROXIDE DISMUTASE CATALYSTS.
ES2145041T3 (en) * 1991-12-10 2000-07-01 Dow Chemical Co BICICLOPOLIAZAMACROCICLOCARBOXYLIC ACID COMPLEXES, THEIR CONJUGATES, PREPARATION AND USE AS CONTRAST AGENTS.
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
WO1996039409A1 (en) * 1995-06-05 1996-12-12 Nitromed, Inc. Nitrosylated and nitrated superoxide oxidants and reductants
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
AU5928396A (en) * 1995-06-07 1996-12-30 Monsanto Company Process for preparing substituted polyazamacrocycles

Also Published As

Publication number Publication date
NO984164L (en) 1998-11-06
WO1997033877A1 (en) 1997-09-18
JP2000508625A (en) 2000-07-11
AU1962497A (en) 1997-10-01
IL125889A0 (en) 1999-04-11
CN1225631A (en) 1999-08-11
EP0891338A1 (en) 1999-01-20
CA2249011A1 (en) 1997-09-18
CZ271198A3 (en) 1999-01-13
KR19990087784A (en) 1999-12-27
BR9708179A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
AU6023796A (en) Manganese or iron complexes of nitrogen-containing macrocycl ic ligands effective as catalysts for dismutating superoxide
DK0968228T3 (en) Calcium phosphopeptide complexes
DE60011446D1 (en) SUBSTITUTED PYRIDINO PENTAAZA MACROCYCLE COMPLEXES WITH SUPEROXIDE DISMUTASE ACTIVITY
ATE275553T1 (en) ISOTHIAZOLE DERIVATIVES USABLE AS ANTICANCER AGENTS
NO984164D0 (en) Bioconjugates of manganese or iron complexes consisting of nitrogen-containing macrocyclic ligands effective as catalysts for the dismutation of superoxide
DE3887566T2 (en) Pyridoxamine chelate compounds, manganese II chelates and their use as NMRI contrast agents.
DE69916531D1 (en) wheel cover
AU7148598A (en) Cast wheel having circumferential lightener pockets
PL324993A1 (en) Bioconjugates of macrocyclic, nitrogen containing manganese complex ligands efficiently acting as catalysts of the superoxidic dismutation reaction
NO984165D0 (en) Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxides
DE59909784D1 (en) Safety lock for the lid
NO996282D0 (en) Homogeneous oxidation catalysis using metal complexes
IL114464A0 (en) Inclusion complexes of ranitidine
ZA925139B (en) Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxicde.
KR960013682U (en) Car Wheel Covers
KR970063001U (en) Car leakage prevention packing structure
IL142813A0 (en) Aromatic derivatives and iron complexes thereof for use as normalising agents of the iron level
KR960004913U (en) Car Hall Cover
TW342786U (en) Simply air-filling car cover
KR970061129U (en) Scaffolding for car wheel escape
KR960030972U (en) Vehicle safety table
KR970049374U (en) Position of the car operating platform
KR960017231U (en) Anti slipper for car wheels
KR970061553U (en) Truck cargo lock
KR970057454U (en) Noise prevention structure for car